SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (Nasdaq: ZGEN) today announced that it has priced an underwritten public offering of 14,000,000 shares of its common stock at a price of $6.00 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $79,000,000. ZymoGenetics has granted the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of common stock to cover overallotments, if any. The offering is expected to close on or about January 12, 2010, subject to satisfaction of customary closing conditions. Leerink Swann LLC is acting as sole book-running manager for the offering. Wedbush Morgan Securities, Inc., William Blair & Company, L.L.C., Canaccord Adams Inc. and McAdams Wright Ragen, Inc. are acting as co-managers for the offering.
